Most popular ETFs | ||||||
iShares Core MSCI World UCITS ETF USD (Acc) | IE00B4L5Y983 | Equity | ETF | |||
Xtrackers MSCI Emerging Markets UCITS ETF 1C | IE00BTJRMP35 | Equity | ETF | |||
Vanguard FTSE All-World UCITS ETF Distributing | IE00B3RBWM25 | Equity | ETF | |||
iShares Global Clean Energy UCITS ETF USD (Dist) | IE00B1XNHC34 | Equity | ETF | |||
ETC Group Physical Bitcoin | DE000A27Z304 | Cryptocurrencies | ETN |
Most popular categories |
Equity, World |
Equity, Dividend strategy |
Bonds, Government, EUR |
The Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C seeks to track the MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 index. The MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 index tracks stocks from developed and emerging countries worldwide. The index selects companies that are expected to derive revenue from technological innovations in the genomic healthcare sector. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance). The parent index is the MSCI ACWI IMI.
MSCI ACWI IMI Genomic Innovation Select ESG Screened 100 (1)
Equity (1581) World (461) Health Care (23) Innovation (13)
Replication |
Physical (Full replication) |
Legal structure | ETF |
Strategy risk | Long-only |
Fund currency | USD |
Currency risk |
Currency unhedged |
Volatility 1 year (in EUR) | - - |
Inception/ Listing Date | 12 July 2022 |
Distribution policy | Accumulating | |
Distribution frequency | - | |
Fund domicile | Ireland | |
Tax data | Bundesanzeiger |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Fund Provider | Xtrackers |
Administrator | State Street Custodial Services (Ireland) Limited |
Investment Advisor | DWS Investments UK Ltd |
Custodian Bank | State Street Custodial Services (Ireland) Limited |
Revision Company | Pricewaterhouse Coopers |
Fiscal Year End | 31 December |
Swiss representative | DWS CH AG |
Swiss paying agent | Deutsche Bank (Suisse) SA |
Germany | 30% tax rebate |
Switzerland | No ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | - |
Swap counterparty | - |
Collateral manager | |
Securities lending | Yes |
Securities lending counterparty |
Select your savings amount:
Broker | Rating | Savings plan offer | Brokerage fee | More information |
---|---|---|---|---|
![]() |
free of charge
|
free of charge
|
More info | |
![]() |
free of charge
|
free of charge
|
More info | |
![]() |
free of charge
|
free of charge
|
More info | |
![]() |
free of charge
|
free of charge
|
More info | |
![]() |
free of charge
|
free of charge
|
More info |
Below you find information about the composition of the Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C.
VERTEX PHARMACEUTICALS ORD |
5.10%
|
ILLUMINA INC |
5.07%
|
THERMO FISHER SCIENTIFIC INC |
4.80%
|
LONZA GRP AG N ORD |
4.74%
|
GILEAD SCIENCES INC |
4.66%
|
BRISTOL-MYERS SQUIBB CO |
4.59%
|
ABBOTT LABORATORIES |
4.45%
|
ROCHE ORD |
4.40%
|
AGILENT TECHNOLOGIES INC |
4.32%
|
ALNYLAM PHARMACEUTICALS ORD |
4.23%
|
Health Care |
97.65%
|
Technology |
0.67%
|
Other |
1.68%
|